These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15670054)

  • 1. Pregnancy and delivery in patients with homozygous or heterozygous R854Q type 2N von Willebrand disease.
    Castaman G; Bertoncello K; Bernardi M; Rodeghiero F
    J Thromb Haemost; 2005 Feb; 3(2):391-2. PubMed ID: 15670054
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G; Eikenboom JC; Contri A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy in women with different types of von Willebrand disease.
    Conti M; Mari D; Conti E; Muggiasca ML; Mannucci PM
    Obstet Gynecol; 1986 Aug; 68(2):282-5. PubMed ID: 3090493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.
    Castaman G; Tosetto A; Rodeghiero F
    Haematologica; 2010 Jun; 95(6):963-9. PubMed ID: 19951969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.
    Hilbert L; Jorieux S; Fontenay-Roupie M; Guicheteau M; Fressinaud E; Meyer D; Mazurier C;
    Br J Haematol; 2004 Oct; 127(2):184-9. PubMed ID: 15461624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
    Hilbert L; Nurden P; Caron C; Nurden AT; Goudemand J; Meyer D; Fressinaud E; Mazurier C;
    Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
    Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2N von Willebrand disease: Characterization and diagnostic difficulties.
    Casonato A; Galletta E; Sarolo L; Daidone V
    Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy.
    Nishino M; Nishino S; Sugimoto M; Shibata M; Tsuji S; Yoshioka A
    Int J Hematol; 1996 Aug; 64(2):127-34. PubMed ID: 8854570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand disease: laboratory aspects of diagnosis and treatment.
    Favaloro EJ; Lillicrap D; Lazzari MA; Cattaneo M; Mazurier C; Woods A; Meschengieser S; Blanco A; Kempfer AC; Hubbard A; Chang A
    Haemophilia; 2004 Oct; 10 Suppl 4():164-8. PubMed ID: 15479392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous C2362F von Willebrand factor induces intracellular retention of mutant von Willebrand factor resulting in autosomal recessive severe von Willebrand disease.
    Tjernberg P; Castaman G; Vos HL; Bertina RM; Eikenboom JC
    Br J Haematol; 2006 May; 133(4):409-18. PubMed ID: 16643449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
    Mazurier C; Meyer D
    Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544
    [No Abstract]   [Full Text] [Related]  

  • 15. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.
    Castaman G; Giacomelli SH; Jacobi P; Obser T; Budde U; Rodeghiero F; Haberichter SL; Schneppenheim R
    J Thromb Haemost; 2010 Sep; 8(9):2011-6. PubMed ID: 20586924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease.
    Casonato A; Gallinaro L; Pontara E; Bernardo L; Sartorello F; Daidone V; Pagnan A
    Thromb Res; 2007; 120(3):451-3. PubMed ID: 17157361
    [No Abstract]   [Full Text] [Related]  

  • 17. Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)--detection of a novel candidate type 2N mutation: C2810T (R854W).
    Bowen DJ; Standen GR; Mazurier C; Gaucher C; Cumming A; Keeney S; Bidwell J
    Thromb Haemost; 1998 Jul; 80(1):32-6. PubMed ID: 9684781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Von Willebrand's disease in pregnancy.
    Leone G; Moneta E; Paparatti G; Boni P
    N Engl J Med; 1975 Aug; 293(9):456. PubMed ID: 1080256
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
    Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
    Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.